13 January 2017

“Battling against scepticism in the Square Mile, Salisbury-based GW Pharmaceuticals has ploughed a lonely furrow as a listed company developing cannabis-based drugs since its flotation in 2001. The biotech firm keeps the location of its two cannabis fields secret; they are somewhere in southern England under 24-hour surveillance. Each plant is registered and genetically fingerprinted so it can be traced if stolen. GW needs special licences from the Home Office for sites, production, storage and exports, and the drug is transported in high-security vans to hospitals where it is put in a safe with opiates such as morphine.”

You can read the rest of the profile at…

https://www.theguardian.com/business/2011/apr/17/gw-pharmaceuticals-justin-gover-cannabis-sativex-multiple-sclerosis